OTC •
Healthcare •
Biotechnology •
Quote as of 11/03/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.003213 mln
Float31.27 mln
EPS
0.04
Marginal
P / E
0.00
Anomalous
Relative Strength
58
/ 100
Slightly ahead
ROE
19.88
Healthy
ROA
-216
Deeply negative
Business Description
Rebus Holdings Inc. is a California-based company founded in 2003 that develops targeted cancer treatments. Its primary drug candidate, RT-AR001, works by blocking adenosine receptors and is injected directly into tumors to improve patient outcomes.